Report
Michael Waterhouse
EUR 101.80 For Business Accounts Only

Baxter’s Margin Improvements Should Offset a Subdued Growth Outlook for 2017

Baxter’s fourth-quarter results of 2% revenue growth and an adjusted operating margin of 15.4% fell mostly in line with our forecast. Our 2017 forecast for $2.14 in adjusted EPS and $1.75 billion in operating cash flow matches management’s outlook for the year even though growth should come in below our current estimate offset by a higher operating margin. Management estimates nearly flat growth for 2017 thanks largely to foreign exchange headwinds, exiting certain less profitable markets, and o...
Underlying
Baxter International Inc.

Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision. The company manages its business based on three geographic segments: Americas (North and South America), Europe, Middle East and Africa and Asia-Pacific.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Michael Waterhouse

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch